Simulations Plus Partners with Large Pharmaceutical Company to Enhance the Mechanistic Oral Absorption (ACAT) Model in GastroPlus®
This webinar will provide an overview of a recent publication which was a collaborative effort from GastroPlus® User Group members.
Simulations Plus Partners with Large Pharmaceutical Company to Add New Capabilities to PKPlus™
Are you ready to integrate in silico modeling & simulation to augment your research activities, but don’t have the in-house skills or resources?
To improve the productivity of science-based research & development enterprises by delivering innovative modeling and simulation software and insightful consulting services.
Ensuring the safety of drug therapies by leveraging our expertise in the areas of drug-induced liver injury, metabolic diseases, and modeling and simulation.
Providing strategic pharmacology and pharmacometric consulting services, PK/PD model development with NONMEM, clinical trial simulations, exposure-response evaluations, dose justification strategies and related data management services.
While our focus for the solutions we provide was initially targeted for pharmaceutical research & development, we have earned a sound reputation in other markets as we develop stronger relationships with regulatory agencies like the U.S. FDA, U.S. EPA, EMA, PMDA, ECHA, and more.
Stay up-to-date with our upcoming conference attendance & presentations, application webinars, and training workshop courses.
Find out how your peers are applying our technology by reviewing journal articles describing various user case studies.